Skip to content
← Back to this collection

PUBLICATIONS · 15020609

Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995).

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2004 Mar 15
First author
Greenberg PL

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2004 Jul 1;22(13):2747
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null

Authors and identifiers

  1. name
    Greenberg PL
    type
    Author
  2. name
    Lee SJ
    type
    Author
  3. name
    Advani R
    type
    Author
  4. name
    Tallman MS
    type
    Author
  5. name
    Sikic BI
    type
    Author
  6. name
    Letendre L
    type
    Author
  7. name
    Dugan K
    type
    Author
  8. name
    Lum B
    type
    Author
  9. name
    Chin DL
    type
    Author
  10. name
    Dewald G
    type
    Author
  11. name
    Paietta E
    type
    Author
  12. name
    Bennett JM
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Greenberg PL
    type
    Author
  2. name
    Lee SJ
    type
    Author
  3. name
    Advani R
    type
    Author
  4. name
    Tallman MS
    type
    Author
  5. name
    Sikic BI
    type
    Author
  6. name
    Letendre L
    type
    Author
  7. name
    Dugan K
    type
    Author
  8. name
    Lum B
    type
    Author
  9. name
    Chin DL
    type
    Author
  10. name
    Dewald G
    type
    Author
  11. name
    Paietta E
    type
    Author
  12. name
    Bennett JM
    type
    Author
bibliography ids
  1. nci-bib-a9513a7af270415a73f7b547
book metadata
content sha256
9e998e045875db138dfef7132cbf01ade4683ed2de8bd433d08b7e3f9a480080
document type
citation
dois
  1. 10.1200/JCO.2004.07.048
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:15020609
immutable id
pubmed:15020609@9e998e045875db138dfef7132cbf01ade4683ed2de8bd433d08b7e3f9a480080
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
6
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1078-86
volume
22
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2004 Jul 1;22(13):2747
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
outcomes validated
false
pmid
15020609
provenance
batch id
aee154f17d1b0501fe1f
provider
NCBI PubMed ESummary
record sha256
81ca12ee381dff3406b5b6f1e2be9722c8608589feed775b6e33edc47d700152
response sha256
75a826407a9022d376294c7400982e19a458458cea55b2628fd3fddd75bc0f08
retrieved at
2026-09-09T23:45:53.270896+00:00
publication date
display
2004 Mar 15
precision
day
year
2004
publication types
  1. Clinical Trial
  2. Clinical Trial, Phase III
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
  7. Research Support, U.S. Gov't, P.H.S.
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/15020609/
title
Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995).

Preserved source evidence · Not medical advice